Wuxi Biologics (Cayman) (2269N) Stock Forecast & Price Target
2269N Analyst Ratings
Strong Buy
12Buy2Hold0Sell
Based on 14 analysts giving stock ratings to Wuxi Biologics (Cayman) in the past 3 months
2269N Stock 12 Month Forecast
Average Price Target
MXN 141.54▲(114.45% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is MXN 141.54 with a high forecast of MXN 155.58 and a low forecast of MXN 116.03. The average price target represents a 114.45% change from the last price of MXN 66.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 155.58
AverageMXN 141.54
LowMXN 116.03
Highest Price TargetHighestMXN 155.58Average Price TargetMXN 141.54Lowest Price TargetLowestMXN 116.03
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Guotai Haitong | MXN 152.80 | buy | 131.52%Upside | Reiterated | 09/17/26 | ||
| Laurence Tam | Morgan Stanley | MXN 134.97 | buy | 104.51%Upside | Reiterated | 09/16/26 | ||
| Unknown AnalystNot Ranked | Zhongtai Securities | MXN 145.27 | buy | 120.11%Upside | Reiterated | 09/04/26 | ||
| Chen Chen | UBS | MXN 121.00→MXN 146.81 | buy | 122.45%Upside | Reiterated | 09/01/26 | ||
| Jill Wu | CMB International Securities | MXN 142.08 | buy | 115.27%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | Citi | MXN 99.45→MXN 146.81 | buy | 122.45%Upside | Reiterated | 08/27/26 | ||
| Cui Cui | Jefferies | MXN 142.08 | buy | 115.27%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | CICC | MXN 113.66→MXN 142.08 | buy | 115.27%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | CLSA | MXN 122.90→MXN 155.58 | buy | 135.72%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | MXN 142.08 | buy | 115.27%Upside | Reiterated | 08/27/26 | ||
| Unknown AnalystNot Ranked | Goldman Sachs | MXN 102.06→MXN 116.03 | hold | 75.80%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | Daiwa | MXN 139.71 | buy | 111.68%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | MXN 132.61 | hold | 100.92%Upside | Reiterated | 08/26/26 | ||
| Unknown AnalystNot Ranked | Nomura | MXN 121.67→MXN 142.60 | buy | 116.06%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | J.P. Morgan | MXN 111.29 | buy | 68.63%Upside | Reiterated | 08/03/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 09/17/26 | MXN 152.80 | buy | 131.52%Upside | Reiterated | Guotai Haitong | ||
| Laurence Tam | 09/16/26 | MXN 134.97 | buy | 104.51%Upside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 09/04/26 | MXN 145.27 | buy | 120.11%Upside | Reiterated | Zhongtai Securities | ||
| Chen Chen | 09/01/26 | MXN 121.00→MXN 146.81 | buy | 122.45%Upside | Reiterated | UBS | ||
| Jill Wu | 08/27/26 | MXN 142.08 | buy | 115.27%Upside | Reiterated | CMB International Securities | ||
| Unknown AnalystNot Ranked | 08/27/26 | MXN 99.45→MXN 146.81 | buy | 122.45%Upside | Reiterated | Citi | ||
| Cui Cui | 08/27/26 | MXN 142.08 | buy | 115.27%Upside | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 08/27/26 | MXN 113.66→MXN 142.08 | buy | 115.27%Upside | Reiterated | CICC | ||
| Unknown AnalystNot Ranked | 08/27/26 | MXN 122.90→MXN 155.58 | buy | 135.72%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 08/27/26 | MXN 142.08 | buy | 115.27%Upside | Reiterated | Citic Securities | ||
| Unknown AnalystNot Ranked | 08/26/26 | MXN 102.06→MXN 116.03 | hold | 75.80%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 08/26/26 | MXN 139.71 | buy | 111.68%Upside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 08/26/26 | MXN 132.61 | hold | 100.92%Upside | Reiterated | Bank of America Securities | ||
| Unknown AnalystNot Ranked | 08/25/26 | MXN 121.67→MXN 142.60 | buy | 116.06%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 08/03/26 | MXN 111.29 | buy | 68.63%Upside | Reiterated | J.P. Morgan |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Wuxi Biologics (Cayman)
3 Months
Success Rate6/8 ratings generated profit
75%
Average Return
+16.49%
Copying Jialin Zhang's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +16.49% per trade.
1 Year
Success Rate7/8 ratings generated profit
88%
Average Return
+67.47%
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +67.47% per trade.
2 Years
Success Rate7/8 ratings generated profit
88%
Average Return
+125.30%
Copying Jialin Zhang's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +125.30% per trade.
2269N Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 0 | 0 | 0 |
| Buy | 8 | 18 | 19 | 14 | 4 |
| Hold | 0 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 21 | 21 | 16 | 4 |
In the current month, 2269N has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2269N average Analyst price target in the past 3 months is 141.54.
2269N Financial Forecast
HighMXN 2.05
ConsensusMXN 2.00
LowMXN 1.95
2269N Earnings Forecast
Next quarter’s earnings estimate for 2269N is MXN 2.00 with a range of MXN 1.95 to MXN 2.05. The previous quarter’s EPS was MXN 1.59. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 38.4B
ConsensusMXN 38.1B
LowMXN 37.9B
2269N Sales Forecast
Next quarter’s sales forecast for 2269N is MXN 38.13B with a range of MXN 37.89B to MXN 38.36B. The previous quarter’s sales results were MXN 31.46B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
2269N Stock Forecast FAQ
What is MX:2269N’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman)’s 12-month average price target is Mex$141.54.
What is MX:2269N’s upside potential, based on the analysts’ average price target?
Wuxi Biologics (Cayman) has 114.45% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Wuxi Biologics (Cayman) a Buy, Sell or Hold?
Wuxi Biologics (Cayman) has a consensus rating of Strong Buy, which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
What is Wuxi Biologics (Cayman)’s share price target?
The average share price target for Wuxi Biologics (Cayman) is Mex$141.54. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$155.58, and the lowest forecast is Mex$116.03. The average share price target represents a 114.45% increase from the current price of Mex$66.
What do analysts say about Wuxi Biologics (Cayman)?
Wuxi Biologics (Cayman)’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Wuxi Biologics (Cayman)?
To buy shares of MX:2269N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
